138 related articles for article (PubMed ID: 35465844)
21. Discovery of potential HER2 inhibitors from
Balogun TA; Iqbal MN; Saibu OA; Akintubosun MO; Lateef OM; Nneka UC; Abdullateef OT; Omoboyowa DA
J Biomol Struct Dyn; 2022; 40(23):12772-12784. PubMed ID: 34514973
[TBL] [Abstract][Full Text] [Related]
22. Screening of potential drug for Alzheimer's disease: a computational study with GSK-3 β inhibition through virtual screening, docking, and molecular dynamics simulation.
Elangovan ND; Dhanabalan AK; Gunasekaran K; Kandimalla R; Sankarganesh D
J Biomol Struct Dyn; 2021 Nov; 39(18):7065-7079. PubMed ID: 32779973
[TBL] [Abstract][Full Text] [Related]
23. Encapsulation mechanism of α-mangostin by β-cyclodextrin: Methods of molecular docking and molecular dynamics.
Triwahyuningtyas D; Megantara S; Hong TT; Yusuf M; Muchtaridi M
J Adv Pharm Technol Res; 2021; 12(3):250-253. PubMed ID: 34345603
[TBL] [Abstract][Full Text] [Related]
24. Gamma-mangostin isolated from garcinia mangostana suppresses colon carcinogenesis and stemness by downregulating the GSK3β/β-catenin/CDK6 cancer stem pathway.
Wu AT; Yeh YC; Huang YJ; Mokgautsi N; Lawal B; Huang TH
Phytomedicine; 2022 Jan; 95():153797. PubMed ID: 34802869
[TBL] [Abstract][Full Text] [Related]
25. Alpha-mangostin, piperine and beta-sitosterol as hepatitis C antivirus (HCV): In silico and in vitro studies.
Saputro AH; Amelia T; Mahardhika AB; Widyawaruyanti A; Wahyuni TS; Permanasari AA; Artarini AA; Tjahjono DH; Damayanti S
Heliyon; 2023 Sep; 9(9):e20141. PubMed ID: 37809693
[TBL] [Abstract][Full Text] [Related]
26. α-Mangostin induces oxidative damage, mitochondrial dysfunction, and apoptosis in a triple-negative breast cancer model.
Cruz-Gregorio A; Aranda-Rivera AK; Aparicio-Trejo OE; Medina-Campos ON; Sciutto E; Fragoso G; Pedraza-Chaverri J
Phytother Res; 2023 Aug; 37(8):3394-3407. PubMed ID: 37012651
[TBL] [Abstract][Full Text] [Related]
27. Screening of
Chandel S; Singh R; Gautam A; Ravichandiran V
J Biomol Struct Dyn; 2022; 40(23):12827-12840. PubMed ID: 34569452
[TBL] [Abstract][Full Text] [Related]
28. Molecular dynamics simulation of Fe-NO
Rosilawati NE; Yusuf M; Kartamihardja AHS; Samsuddin S; Muchtaridi M
J Adv Pharm Technol Res; 2021; 12(2):113-119. PubMed ID: 34159140
[TBL] [Abstract][Full Text] [Related]
29. Structure-based virtual screening of anti-breast cancer compounds from
Gnanaselvan S; Yadav SA; Manoharan SP
J Biomol Struct Dyn; 2024 Apr; 42(6):3267-3285. PubMed ID: 37194295
[TBL] [Abstract][Full Text] [Related]
30. Etoposide and doxorubicin enhance the sensitivity of triple negative breast cancers through modulation of TRAIL-DR5 axis.
Das S; Tripathi N; Siddharth S; Nayak A; Nayak D; Sethy C; Bharatam PV; Kundu CN
Apoptosis; 2017 Oct; 22(10):1205-1224. PubMed ID: 28702823
[TBL] [Abstract][Full Text] [Related]
31. AMPK inhibits MTDH expression via GSK3β and SIRT1 activation: potential role in triple negative breast cancer cell proliferation.
Gollavilli PN; Kanugula AK; Koyyada R; Karnewar S; Neeli PK; Kotamraju S
FEBS J; 2015 Oct; 282(20):3971-85. PubMed ID: 26236947
[TBL] [Abstract][Full Text] [Related]
32. Revealing the Inhibition Mechanism of RNA-Dependent RNA Polymerase (RdRp) of SARS-CoV-2 by Remdesivir and Nucleotide Analogues: A Molecular Dynamics Simulation Study.
Wakchaure PD; Ghosh S; Ganguly B
J Phys Chem B; 2020 Nov; 124(47):10641-10652. PubMed ID: 33190493
[TBL] [Abstract][Full Text] [Related]
33. Propolin G-Suppressed Epithelial-to-Mesenchymal Transition in Triple-Negative Breast Cancer Cells via Glycogen Synthase Kinase 3β-Mediated Snail and HDAC6-Regulated Vimentin Degradation.
Pai JT; Chen XH; Leu YL; Weng MS
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163593
[TBL] [Abstract][Full Text] [Related]
34.
Bouricha EM; Hakmi M; Akachar J; Zouaidia F; Ibrahimi A
J Biomol Struct Dyn; 2022 Jul; 40(11):5203-5210. PubMed ID: 33402049
[TBL] [Abstract][Full Text] [Related]
35. Molecular docking and molecular dynamics simulations studies on β-glucosidase and xylanase
Bahaman AH; Wahab RA; Abdul Hamid AA; Abd Halim KB; Kaya Y
J Biomol Struct Dyn; 2021 Apr; 39(7):2628-2641. PubMed ID: 32248752
[TBL] [Abstract][Full Text] [Related]
36.
Oyewusi HA; Huyop F; Wahab RA; Hamid AAA
J Biomol Struct Dyn; 2022; 40(19):9332-9346. PubMed ID: 34014147
[TBL] [Abstract][Full Text] [Related]
37. The structural basis of the autoinhibition mechanism of glycogen synthase kinase 3β (GSK3β): molecular modeling and molecular dynamics simulation studies.
Mou L; Dou W; Meng G; Sun K; Chen X
J Biomol Struct Dyn; 2020 Apr; 38(6):1741-1750. PubMed ID: 31057052
[TBL] [Abstract][Full Text] [Related]
38. Kaempferol as a Potential PAK4 Inhibitor in Triple Negative Breast Cancer: Extra Precision Glide Docking and Free Energy Calculation.
Arowosegbe MA; Amusan OT; Adeola SA; Adu OB; Akinola IA; Ogungbe BF; Omotuyi OI; Saibu GM; Ogunleye AJ; Kanmodi RI; Lugbe NE; Ogunmola OJ; Ajayi DC; Ogun SO; Oyende FO; Bello AO; Ishola PG; Obasieke PE
Curr Drug Discov Technol; 2020; 17(5):682-695. PubMed ID: 31441728
[TBL] [Abstract][Full Text] [Related]
39. Quantum evaluation and therapeutic activity of (E)-N-(4-methoxyphenyl)-2-(4-(3-oxo-3-phenylprop-1-en-1-yl) phenoxy)acetamide and its modified derivatives against EGFR and VEGFR-2 in the treatment of triple-negative cancer via in silico approach.
Ipinloju N; Ibrahim A; da Costa RA; Adigun TB; Olubode SO; Abayomi KJ; Aiyelabegan AO; Esan TO; Muhammad SA; Oyeneyin OE
J Mol Model; 2023 Apr; 29(5):159. PubMed ID: 37099048
[TBL] [Abstract][Full Text] [Related]
40. Molecular docking and molecular dynamics simulations of a mutant
Anuar NFSK; Wahab RA; Huyop F; Amran SI; Hamid AAA; Halim KBA; Hood MHM
J Biomol Struct Dyn; 2021 Apr; 39(6):2079-2091. PubMed ID: 32174260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
